US Assisted Reproductive Technology (ART) Market to Hit

Chicago, March 24, 2022 (GLOBE NEWSWIRE) — According to the Arizton research report, the rise in the prevalence of infertility, the increase in the number of fertility clinics, the changing lifestyle of people leading to infertility, rising acceptance of ART procedure are some of the factors driving the United States Assisted Reproductive Technology (ART) market growth over the forecast period.

Other factors include growing number of ART device manufacturing companies, high investments from private and public players and increase in financial aid programs which are also contributing to the growth of the overall reproductive technology market. assisted.

Assisted Reproductive Technology (ART) Scope of the market report

MARKET SIZE (2027) $4.5 billion
CAGR (2022-2027) 7% (2022-2027)
MARKET SEGMENT BY TYPE Services (Source (frozen non-donor, fresh non-donor, fresh donor and frozen donor)
MARKET SEGMENT BY AGE GROUP Between 35 and 40, under 35 and over 40
MARKET SEGMENT BY TECHNIQUE In virto fertilization (IVF), frozen embryo transfer (FET) and others)
MARKET SEGMENT BY DEVICES Product (consumables, media and equipment)
MARKET SEGMENT BY END USER Fertility clinics and hospitals

Click here to download the free sample report

Increase acceptance ohf Artistic procedures

The growing popularity of single women opting for motherhood through organizations such as Single Mothers by Choice and Choice Mom is fueling the demand for ART. Growing awareness of the availability of ART, its success rate, and its benefits, especially in developing economies, is also increasing the demand for ART. For example, the aggressive marketing strategies of fertility clinics, the availability of flexible payment options, and the increase in digital marketing of fertility services by private fertility centers are driving positive awareness of the fertility industry. fertility and its services.

Key offers:

  • Market Size and Forecast by Revenue | 2021−2027
  • Market Dynamics – Key Trends, Growth Drivers, Restraints and Investment Opportunities
  • Market Segmentation – A detailed analysis by type, age group, technique and devices
  • Competitive Landscape – 6 key vendors and 8 other top manufacturers, and 38 top ART service providers are profiled in the report

Increase in venture capital and private equity investments in infertility services

The entry of venture capitalists and private capital is renewing the entire fertility services industry. Some spend on advertising and a deliberate strategy to reach working married women who are not yet trying to conceive. New investors are discovering the appeal of infertility treatment after seeing the success of recent investments and establishing fertility clinics with sophisticated infrastructure.

For a free sample, click:

US Assisted Reproductive Technology (AT) Market Segmentation Analysis

Segmentation by type

  • Services
    • Source
      • Non-donor frozen
      • Fresh non-donor
      • fresh donor
      • Donor Frozen

Segmentation by age range

  • Between 35 & 40 years old
  • Under 35
  • Over 40 years

Segmentation by Technical

  • In Virto Fertilization (IVF)
  • Frozen Embryo Transfer (FET)
  • Others

Segmentation by Devices

  • Product
    • Consumables
    • Media
    • Equipment
  • Final user
    • Fertility clinics
    • Hospitals

Assisted Reproductive Technology in the United States (ART) Overview of market vendors

Major vendors in the market include Cooper, Cook Medical, FUJIFILM Irvine Scientific, Hamilton Throne, Merck KGaA, and Vitrolife. With the growing demand for infertility treatment in the United States, the market share of these vendors is expected to increase in the coming years. However, the big players face fierce competition from emerging players. In addition, major players are forming strategic alliances by entering into co-marketing agreements to increase their competitiveness and penetration in the U.S. Assisted Reproductive Technology (ART) market.

Other important suppliers include Carl Zeiss, Esco Lifesciences, Gynemed, Kitazato USA, Nidacon, Rocket Medical, Thermo Fisher Scientific and Thomas Medical. These vendors compete with each other by providing affordable ART devices to fertility clinics and hospitals. Although the major players are dominating the market and other players are also focusing on providing low cost ART solutions to their customers. Vendors are actively aiming to introduce innovative devices to penetrate and utilize the huge growth potential prevailing in the market. Technological advancements and innovations in the field of ART provide tremendous growth opportunity for vendors.

Click here to download the free sample report

Read some of the best-selling reports:

On Arizona:

Arizton Advisory and Intelligence is an innovation and quality-driven company that provides industry-leading research solutions to clients around the world. We excel in providing comprehensive market intelligence reports and advisory and consultancy services.

We offer comprehensive market research reports on industries such as consumer goods and retail technology, automotive and mobility, smart technologies, healthcare and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers and trend forecasts.

Arizton has an exuberant and experienced team of analysts who are proficient in generating incisive reports. Our specialized analysts have exemplary skills in market research. We train our team in advanced research practices, techniques and ethics to surpass the production of impregnable research reports.

Click here to contact us

Call: +1-312-235-2040

+1 302 469 0707

Back To Top